Neurological care and risk of hospital mortality for patients with myasthenia gravis in England

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 79, Issue 4, 2008, Pages 421-425

  Hill, M ^a   Ben Shlomo, Yoav ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL FEATURE; CLINICAL PRACTICE; COMORBIDITY; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYASTHENIA GRAVIS; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; UNITED KINGDOM;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; ENGLAND; FEMALE; HOSPITAL DEPARTMENTS; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; NEUROLOGY; RETROSPECTIVE STUDIES; RISK; RISK FACTORS; SPECIALTIES, MEDICAL; SURVIVAL ANALYSIS;

EID: 41149086716     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2007.118950     Document Type: Article

References (19)

1. Grob D, Arsura EL, Brunner NG, et al. The course of myasthenia gravis and therapies affecting outcome. Ann N Y Acad Sci 1987;505:472-99.
2. Phillips LH, Torner JC. Epidemiologic evidence for a changing natural history of myasthenia gravis. Neurology 1996;47:1233-8.
3. Christensen PB, Jensen TS, Tsiropoulos I, et al. Mortality and survival in myasthenia gravis: a Danish population based study. J Neurol Neurosurg Psychiatry 1998;64:78-83.
4. Schon F, Drayson M, Thompson RA. Myasthenia gravis and elderly people. Age Ageing 1996;25:56-8.
5. Aarli JA. Late-onset myasthenia gravis: a changing scene. Arch Neurol 1999;56:25-7.
6. Vincent A, Clover L, Buckley C, et al. Evidence of underdiagnosis of myasthenia gravis in older people. J Neurol Neurosurg Psychiatry 2003;74:1105-8.
7. Hillen ME, Sage JI. Proving the worth of neurologists. Neurology 1996;46:276-7.
8. Steiger MJ, Enevoldson TP, Hammans SR, et al. Influence of obtaining a neurological opinion on the diagnosis and management of hospital inpatients. J Neurol Neurosurg Psychiatry 1996;61:653-4.
9. Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ 1996;312:1215-18.
10. Rodrigues L, Kirkwood BR. Case-control designs in the study of common disease: updates on the demise of the rare disease assumption and the choice of sampling scheme for controls. Int J Epidemiol 1990;19:205-13.
11. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987;40:373-83.
12. Townsend P, Phillimore P, Beattie A. Health and deprivation: Inequality and the North. London: Croom Helm, 1988.
13. Preen DB, D'Arcy C, Holman J, et al. Hospital chart review provided more accurate comorbidity information than data from a general practitioner survey or an administrative database. J Clin Epidemiol 2004;57:1295-304.
14. Mahadeva R, Webb K, Westerbeek RC, et al. Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study. BMJ 1998;316:1771-5.
15. Walters S, Britton J, Hodson ME. Hospital care for adults with cystic fibrosis: an overview and comparison between special cystic fibrosis clinics and general clinics using a patient guestionnaire. Thorax 1994;49:300-6.
16. Bachmann MO, Alderson D, Peters TJ, et al. Influence of specialization on the manangement and outcome of paients with pancreatic cancer. Br J Surg 2003;90:171-7.
17. Kingsmore D, Ssemwogerere A, Hole D, et al. Specialisation and breast cancer survival in the screening era. Br J Cancer 2003;88:1708-12.
18. McArdle CS, Hole DJ. Influence of volume and specialization on survival following surgery for colorectal cancer. Br J Surg 2004;91:610-17.
19. Lunn JN, Devlin HB. Lessons from the confidential enquiry into perioperative deaths in three NHS regions. Lancet 1987;2:1384-7.